1 Min Read
April 12 (Reuters) - Amarin Corporation PLC:
* VASCEPA SHOWED FALL IN ATHEROGENIC LIPID, INFLAMMATORY MARKERS IN STATIN-TREATED PATIENTS WITH REDUCED KIDNEY FUNCTION, PERSISTENT HIGH TRIGLYCERIDES Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.